Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study
- 15 December 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 171 (2) , 110-114
- https://doi.org/10.1016/s0022-510x(99)00260-9
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Differences in Medical and Surgical Therapy for Stroke Prevention Between Leading Experts in North America and Western EuropeStroke, 1998
- Aspirin in Ischemic Cerebrovascular DiseaseStroke, 1996
- Aspirin WarsStroke, 1996
- Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- US National Survey of Physician Practices for the Secondary and Tertiary Prevention of Ischemic StrokeStroke, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Aspirin response and failure in cerebral infarction.Stroke, 1993
- Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.Stroke, 1992
- Dose‐Dependent Aspirin Hydrolysis and Platelet Aggregation in Patients with AtherosclerosisThe Journal of Clinical Pharmacology, 1992
- Secondary prevention of vascular disease by prolonged antiplatelet treatmentBMJ, 1988